Abstract
During Feb-Apr 2020, many countries implemented non-pharmaceutical interventions, such as school closures and lockdowns, with variable schedules, to control the COVID-19 pandemic caused by the SARS-CoV-2 virus. Overall, these interventions seem to have successfully reduced the spread of the pandemic. We hypothesise that the official and effective start date of such interventions can significantly differ, for example due to slow adoption by the population, or because the authorities and the public are unprepared. We fit an SEIR model to case data from 12 countries to infer the effective start dates of interventions and contrast them with the official dates. We find mostly late, but also early effects of interventions. For example, Italy implemented a nationwide lockdown on Mar 11, but we infer the effective date on Mar 17 (±2.99 days 95% CI). In contrast, Germany announced a lockdown on Mar 22, but we infer an effective start date on Mar 19 (± 1.05 days 95% CI). We demonstrate that differences between the official and effective start of NPIs can distort conclusions about their impact, and discuss potential causes and consequences of our results.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Israel Science Foundation 3811/19, 552/19, and 1399/17.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not needed, this study is a statistical analysis of publicly available data.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
